A detailed history of Armistice Capital, LLC transactions in Chimerix Inc stock. As of the latest transaction made, Armistice Capital, LLC holds 2,208,000 shares of CMRX stock, worth $6.6 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,208,000
Previous 2,224,000 0.72%
Holding current value
$6.6 Million
Previous $1.96 Million 4.91%
% of portfolio
0.03%
Previous 0.03%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.77 - $1.07 $12,320 - $17,120
-16,000 Reduced 0.72%
2,208,000 $2.05 Million
Q2 2024

Aug 14, 2024

SELL
$0.87 - $1.05 $34,800 - $42,000
-40,000 Reduced 1.77%
2,224,000 $1.96 Million
Q1 2024

May 15, 2024

SELL
$0.91 - $1.26 $303,940 - $420,840
-334,000 Reduced 12.86%
2,264,000 $2.4 Million
Q4 2023

Feb 13, 2024

SELL
$0.9 - $1.06 $246,600 - $290,440
-274,000 Reduced 9.54%
2,598,000 $2.49 Million
Q3 2023

Nov 14, 2023

SELL
$0.94 - $1.23 $285,760 - $373,920
-304,000 Reduced 9.57%
2,872,000 $2.76 Million
Q2 2023

Aug 14, 2023

SELL
$1.1 - $1.54 $110,000 - $154,000
-100,000 Reduced 3.05%
3,176,000 $3.84 Million
Q1 2023

May 15, 2023

BUY
$1.19 - $2.09 $90,440 - $158,840
76,000 Added 2.38%
3,276,000 $4.13 Million
Q4 2022

Feb 14, 2023

BUY
$1.67 - $2.35 $741,480 - $1.04 Million
444,000 Added 16.11%
3,200,000 $5.95 Million
Q3 2022

Nov 14, 2022

SELL
$1.81 - $2.76 $1.39 Million - $2.12 Million
-768,000 Reduced 21.79%
2,756,000 $5.32 Million
Q2 2022

Aug 15, 2022

BUY
$1.34 - $5.34 $4.72 Million - $18.8 Million
3,524,000 New
3,524,000 $7.33 Million
Q4 2018

Feb 14, 2019

SELL
$2.24 - $3.9 $2.91 Million - $5.07 Million
-1,300,000 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$3.58 - $4.9 $150,360 - $205,800
42,000 Added 3.34%
1,300,000 $5.06 Million
Q2 2018

Aug 14, 2018

BUY
$4.43 - $5.14 $1 Million - $1.17 Million
226,800 Added 21.99%
1,258,000 $5.99 Million
Q1 2018

May 15, 2018

BUY
$4.65 - $5.9 $4.8 Million - $6.08 Million
1,031,200 New
1,031,200 $5.36 Million

Others Institutions Holding CMRX

About CHIMERIX INC


  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $262M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track Armistice Capital, LLC Portfolio

Follow Armistice Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.